Full Text Journal Articles by
Author Michael G Martin

Advertisement

Find full text journal articles








Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.

Matthew K Stein, Forrest W Williard, Joanne Xiu, Miriam W Tsao, Michael G Martin, Benjamin W Deschner, Paxton V Dickson, Evan S Glazer, Danny Yakoub, David Shibata, Axel F Grothey, Philip A Philip, Jimmy J Hwang, Anthony F Shields, John L Marshall, W Michael Korn, Heinz-Josef Lenz, Jeremiah L Deneve,

BACKGROUND AND OBJECTIVES:Peritoneal metastases (PM) from primary colorectal cancer (pCRC) are associated with poor outcomes; however, molecular differences are not well defined. METHODS:We compared unpaired tumor profiles of patients with pCRC and PM from Caris Life Sciences. Testing included next-generation sequencing of 592 genes, microsatellite instability (MSI) and tumor mutational ... Read more >>

J Surg Oncol (Journal of surgical oncology)
[2020, 121(8):1320-1328]

Cited: 0 times

View full text PDF listing >>



Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.

Martin S Tallman, Eunice S Wang, Jessica K Altman, Frederick R Appelbaum, Vijaya Raj Bhatt, Dale Bixby, Steven E Coutre, Marcos De Lima, Amir T Fathi, Melanie Fiorella, James M Foran, Aric C Hall, Meagan Jacoby, Jeffrey Lancet, Thomas W LeBlanc, Gabriel Mannis, Guido Marcucci, Michael G Martin, Alice Mims, Margaret R O'Donnell, Rebecca Olin, Deniz Peker, Alexander Perl, Daniel A Pollyea, Keith Pratz, Thomas Prebet, Farhad Ravandi, Paul J Shami, Richard M Stone, Stephen A Strickland, Matthew Wieduwilt, Kristina M Gregory, , Lydia Hammond, Ndiya Ogba,

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2019, 17(6):721-749]

Cited: 2 times

View full text PDF listing >>



Advertisement

Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.

Brennan McCullar, Manjari Pandey, George Yaghmour, Felicia Hare, Kruti Patel, Matthew K Stein, Rebecca Feldman, Jason C Chandler, Michael G Martin,

In the original publication, the sixth author name was published incorrectly as Matthew Stein. The correct author name should read as Matthew K Stein. ... Read more >>

Breast Cancer Res. Treat. (Breast cancer research and treatment)
[2019, 173(1):243]

Cited: 0 times

View full text PDF listing >>



Age-Related Chromosomal Aberrations in Patients with Diffuse Large B-Cell Lymphoma: An In Silico Approach.

Eric J Vick, Noah Richardson, Kruti Patel, Glenda M Delgado Ramos, Alaa Altahan, Taylor Alloway, Michael G Martin,

Background:In diffuse large B-cell lymphoma (DLBCL), chromosomal aberrations are known to increase with advancing age. Our study aims to determine if there are other genetic aberrations associated with DLBCL based on age. Methods:Using the Mitelman Database of Genetic Aberrations, we were able to find 749 cases of DLBCL with genomic ... Read more >>

World J Oncol (World journal of oncology)
[2018, 9(4):97-103]

Cited: 0 times

View full text PDF listing >>



Desmoplastic small round cell tumor: A nationwide study of a rare sarcoma.

Zachary E Stiles, Paxton V Dickson, Evan S Glazer, Andrew J Murphy, Andrew M Davidoff, Stephen W Behrman, Michael W Bishop, Michael G Martin, Jeremiah L Deneve,

Desmoplastic small round cell tumor (DSRCT) is a rare peritoneal surface malignancy. Current research is limited by the scarcity of this disease.Patients with DSRCT were identified in the 2004-2014 NCDB. Factors affecting overall survival (OS) were assessed. Additionally, trends were examined based on the volume of cases treated at individual ... Read more >>

J Surg Oncol (Journal of surgical oncology)
[2018, 117(8):1759-1767]

Cited: 3 times

View full text PDF listing >>



Evaluation of Detection Methods and Values of Circulating Vascular Endothelial Growth Factor in Lung Cancer.

Sumin Guo, Michael G Martin, Cheng Tian, Jinglin Cui, Lishi Wang, Shucai Wu, Weikuan Gu,

Lung cancer is the deadliest cancer in the world. Angiogenesis plays a crucial role of the incidence, progression, and metastasis in lung cancer. Angiogenesis inhibitors are used to treat non-small cell lung cancer (NSCLC) patients, and the molecular biomarkers are also being assessed to predict treatment response/therapeutic response and patients' ... Read more >>

J Cancer (Journal of Cancer)
[2018, 9(7):1287-1300]

Cited: 1 time

View full text PDF listing >>



Early experience with cytoreduction and hyperthermic intraperitoneal chemotherapy at a newly developed center for peritoneal malignancy.

Whitney L Guerrero, Gitonga Munene, Paxton V Dickson, Dina Darby, Andrew M Davidoff, Michael G Martin, Evan S Glazer, David Shibata, Jeremiah L Deneve,

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) has improved outcomes for patients with peritoneal carcinomatosis (PC). We present our experience from a newly developed peritoneal surface malignancy program.An IRB approved retrospective review was performed for the first 50 patients treated with CRS/HIPEC with clinicopathologic data described.Patients treated with CRS/HIPEC were ... Read more >>

J Gastrointest Oncol (Journal of gastrointestinal oncology)
[2018, 9(2):338-347]

Cited: 0 times

View full text PDF listing >>



Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease.

Zachary E Stiles, Stephen W Behrman, Jeremiah L Deneve, Evan S Glazer, Lei Dong, Jim Y Wan, Michael G Martin, Paxton V Dickson,

Outcomes and recommendations regarding adjuvant therapy (AT) for stage I ampullary adenocarcinoma (AAC) are inadequately described. We sought to determine factors associated with survival and better define the impact of AT.The NCDB was queried for stage I AAC patients undergoing resection. We evaluated variables influencing the administration of AT and ... Read more >>

J Surg Oncol (Journal of surgical oncology)
[2018, 117(7):1500-1508]

Cited: 2 times

View full text PDF listing >>



Adjuvant Therapy in Resected Melanoma.

Nick Thomson, Rachel Doerr, Michael G Martin,

N. Engl. J. Med. (The New England journal of medicine)
[2018, 378(7):678-679]

Cited: 1 time

View full text PDF listing >>



Navigational bronchoscopy-guided dye marking to assist resection of a small lung nodule.

Jennifer L Sullivan, Michael G Martin, Benny Weksler,

Electromagnetic navigational bronchoscopy (ENB) can be used to dye mark nodules that are difficult to identify during minimally invasive lung resection thoracic surgery. This case report describes the technique of ENB to identify and resect a suspicious small pulmonary nodule in a patient undergoing resection of lung adenocarcinoma. ... Read more >>

J Vis Surg (Journal of visualized surgery)
[2017, 3:131]

Cited: 0 times

View full text PDF listing >>



Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.

Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, Jessica K Altman, Frederick R Appelbaum, Daniel A Arber, Vijaya Bhatt, Dale Bixby, William Blum, Steven E Coutre, Marcos De Lima, Amir T Fathi, Melanie Fiorella, James M Foran, Steven D Gore, Aric C Hall, Patricia Kropf, Jeffrey Lancet, Lori J Maness, Guido Marcucci, Michael G Martin, Joseph O Moore, Rebecca Olin, Deniz Peker, Daniel A Pollyea, Keith Pratz, Farhad Ravandi, Paul J Shami, Richard M Stone, Stephen A Strickland, Eunice S Wang, Matthew Wieduwilt, Kristina Gregory, Ndiya Ogba,

Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2017, 15(7):926-957]

Cited: 64 times

View full text PDF listing >>



NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.

William G Wierda, Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, C Babis Andreadis, Nancy Bartlett, John C Byrd, Paolo Caimi, Luis E Fayad, Richard I Fisher, Martha J Glenn, Thomas M Habermann, Nancy Lee Harris, Francisco Hernandez-Ilizaliturri, Richard T Hoppe, Steven M Horwitz, Mark S Kaminski, Christopher R Kelsey, Youn H Kim, Susan Krivacic, Ann S LaCasce, Michael G Martin, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Kenneth Roberts, Ayman A Saad, Erin D Snyder, Lubomir Sokol, Lode J Swinnen, Julie M Vose, Joachim Yahalom, Mary A Dwyer, Hema Sundar,

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are different manifestations of the same disease and managed in much the same way. The advent of novel CD20 monoclonal antibodies led to the development of effective chemoimmunotherapy regimens. More recently, small molecule inhibitors targeting kinases involved in a number of ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2017, 15(3):293-311]

Cited: 23 times

View full text PDF listing >>



Survival outcomes in the very elderly with DLBCL prior to and after the introduction of rituximab: a US population-based study.

Upama Giri, Michael G Martin,

Blood Adv (Blood advances)
[2017, 1(10):615-618]

Cited: 0 times

View full text PDF listing >>



Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors.

George Yaghmour, Manjari Pandey, Catherine Ireland, Kruti Patel, Sara Nunnery, Daniel Powell, Scott Baum, Eric Wiedower, Lee S Schwartzberg, Michael G Martin,

We evaluated whether tumor genome sequencing to detect the number and type of alterations could be used as a valuable biomarker for judging the potential utility of immune checkpoint inhibitors in patients with advanced cancers.We identified patients with solid tumors who were treated with checkpoint inibitors and had received commercially ... Read more >>

Anticancer Res. (Anticancer research)
[2016, 36(8):4033-4038]

Cited: 7 times

View full text PDF listing >>



Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung.

Brennan McCullar, Manjari Pandey, George Yaghmour, Felicia Hare, Kruti Patel, Matthew Stein, Rebecca Feldman, Jason C Chandler, Michael G Martin,

Small cell carcinoma of the breast is a rare, aggressive form of breast cancer that is associated with extremely poor outcomes [1]. In an effort to identify possible targets for treatment, we utilized comprehensive genomic profiling in small cell carcinoma of the breast. Under an IRB approved protocol, we identified ... Read more >>

Breast Cancer Res. Treat. (Breast cancer research and treatment)
[2016, 158(1):195-202]

Cited: 5 times

View full text PDF listing >>



Unusual, spontaneous aneurysm formation in a patient being treated with ibrutinib for chronic lymphocytic leukemia.

Eric Wiedower, Felicia Hare, Adam Arthur, Jason Chandler, Michael G Martin,

Ther Adv Hematol (Therapeutic advances in hematology)
[2016, 7(4):231-232]

Cited: 1 time

View full text PDF listing >>



Induction of Acute Myeloid Leukemia with Idarubicin, Cytarabine and Cladribine.

Eric Wiedower, Omer Jamy, Michael G Martin,

Daunorubicin and cytarabine has been the standard-of-care for induction therapy for acute myeloid leukemia (AML). Adding cladribine to daunorubicin (60 mg/m(2)) and cytarabine has increased complete remission (CR) rates and median overall survival (OS). However, the efficacy of adding cladribine to 7+3 with other anthracyclines is unknown.We retrospectively evaluated patients ... Read more >>

Anticancer Res. (Anticancer research)
[2015, 35(11):6287-6290]

Cited: 1 time

View full text PDF listing >>



Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary.

Omer Jamy, George Yaghmour, Felicia Hare, Michael G Martin,

BACKGROUND: Primary small cell carcinoma of the ovary (SCCO) is rare, making prognosis and outcomes largely undefined. PATIENTS AND METHODS: Using case listing session of SEER 18 (1973-2010), we examined outcomes for patients with SCCO. Analyses were conducted with SEER(*)Stat 8.1.2, Microsoft Excel 2007 and GraphPad Prism 6. Comparisons were ... Read more >>

Anticancer Res. (Anticancer research)
[2015, 35(5):3091-3095]

Cited: 3 times

View full text PDF listing >>



A population-based analysis of outcomes for small cell carcinoma of the breast by tumor stage and the use of radiation therapy.

Felicia Hare, Smith Giri, Jashmin K Patel, Andrew Hahn, Michael G Martin,

PURPOSE: Primary small cell carcinomas of the breast (SCCB) are rare tumors with limited data on outcomes and treatment strategies. Using a population based approach, we aimed to study outcomes of SCCB and determine whether the use of radiation therapy is associated with better survival among patients with SCCB. METHODS: ... Read more >>

Springerplus (SpringerPlus)
[2015, 4:138]

Cited: 3 times

View full text PDF listing >>



The evolving role of surgery for gastric lymphoma: from curative resection to surgical management of complications.

Elena M Paulus, Martin D Fleming, Ashley A Hendrix, Jeremiah L Deneve, Paxton V Dickson, Alex Mathew, Michael G Martin, Gitonga Munene,

Am Surg (The American surgeon)
[2014, 80(11):E322-4]

Cited: 2 times

View full text PDF listing >>



Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.

Meagan A Jacoby, Michael G Martin, Geoffrey L Uy, Peter Westervelt, John F Dipersio, Amanda Cashen, Keith Stockerl-Goldstein, Ravi Vij, Jingqin Luo, Teresa Reineck, Noel Bernabe, Camille N Abboud,

Clofarabine has shown activity and tolerability in older patients with acute myeloid leukemia (AML). We investigated the safety and tolerability of an oral formulation of clofarabine for consolidation therapy of patients aged 60 and older with AML. In this phase I study, twenty-two patients older than 60 years with AML ... Read more >>

Am. J. Hematol. (American journal of hematology)
[2014, 89(5):487-492]

Cited: 4 times

View full text PDF listing >>



Acute myeloid leukemia, version 2.2013.

Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, Jessica K Altman, Frederick R Appelbaum, Daniel A Arber, Eyal Attar, Uma Borate, Steven E Coutre, Lloyd E Damon, Jeffrey Lancet, Lori J Maness, Guido Marcucci, Michael G Martin, Michael M Millenson, Joseph O Moore, Farhad Ravandi, Paul J Shami, B Douglas Smith, Richard M Stone, Stephen A Strickland, Eunice S Wang, Kristina M Gregory, Maoko Naganuma, ,

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2013, 11(9):1047-1055]

Cited: 57 times

View full text PDF listing >>



Rectal cancer.

Al B Benson, Tanios Bekaii-Saab, Emily Chan, Yi-Jen Chen, Michael A Choti, Harry S Cooper, Paul F Engstrom, Peter C Enzinger, Marwan G Fakih, Charles S Fuchs, Jean L Grem, Steven Hunt, Lucille A Leong, Edward Lin, Michael G Martin, Kilian Salerno May, Mary F Mulcahy, Kate Murphy, Eric Rohren, David P Ryan, Leonard Saltz, Sunil Sharma, David Shibata, John M Skibber, William Small, Constantinos T Sofocleous, Alan P Venook, Christopher G Willett, Deborah A Freedman-Cass, Kristina M Gregory,

These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This ... Read more >>

J Natl Compr Canc Netw (Journal of the National Comprehensive Cancer Network : JNCCN)
[2012, 10(12):1528-1564]

Cited: 73 times

View full text PDF listing >>



Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

Daniel Ka Leung Cheuk, Catherine A Billups, Michael G Martin, Cynthia R Roland, Raul C Ribeiro, Matthew J Krasin, Carlos Rodriguez-Galindo,

BACKGROUND:The authors studied the survival and long-term morbidities of children with nasopharyngeal carcinoma (NPC). METHODS:This was a retrospective review of children with NPC who were treated at St. Jude Children's Research Hospital between 1961 and 2004. Prognostic factors and long term effects of therapy were analyzed. RESULTS:Fifty-nine patients (median age, ... Read more >>

Cancer (Cancer)
[2011, 117(1):197-206]

Cited: 31 times

View full text PDF listing >>



Thrombotic thrombocytopenic purpura induced by trimethoprim-sulfamethoxazole in a Jehovah's Witness.

Michael G Martin, Nicole L Whitlatch, Bijal Shah, Gowthami M Arepally,

We report a case of Thrombotic Thrombocytopenic Purpura occurring as an allergic response to trimethoprim-sulfamethoxazole therapy (Bactrim, Septra) in a Jehovah's Witness patient. The patient presented with fulminant microangiopathic hemolytic anemia and thrombocytopenia within 48 hr of initiating therapy with trimethoprim-sulfamethoxazole. Other symptoms of drug hypersensitivity included nausea, vomiting, urticarial ... Read more >>

Am. J. Hematol. (American journal of hematology)
[2007, 82(7):679-681]

Cited: 10 times

View full text PDF listing >>





Advertisement

Disclaimer
0.9936 s